PharmaCyte Biotech, Inc. Quarterly Return On Assets in % from Q4 2011 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
PharmaCyte Biotech, Inc. quarterly/annual Return On Assets history and growth rate from Q4 2011 to Q2 2024.
  • PharmaCyte Biotech, Inc. Return On Assets for the quarter ending July 31, 2024 was 38.4 %.
  • PharmaCyte Biotech, Inc. annual Return On Assets for 2023 was 0.42 %.
  • PharmaCyte Biotech, Inc. annual Return On Assets for 2022 was -6.13 %, a 88.4% increase from 2021.
  • PharmaCyte Biotech, Inc. annual Return On Assets for 2021 was -52.9 %, a 16.4% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 38.4 +46 May 1, 2024 Jul 31, 2024
Q1 2024 0.46 +5.84 Feb 1, 2024 Apr 30, 2024
Q4 2023 -1.5 +5.13 +77.3% Nov 1, 2023 Jan 31, 2024
Q3 2023 -1.66 +4.77 +74.2% Aug 1, 2023 Oct 31, 2023
Q2 2023 -7.6 -2.34 -44.5% May 1, 2023 Jul 31, 2023
Q1 2023 -5.38 +0.64 +10.6% Feb 1, 2023 Apr 30, 2023
Q4 2022 -6.64 +0.98 +12.9% Nov 1, 2022 Jan 31, 2023
Q3 2022 -6.43 +6.56 +50.5% Aug 1, 2022 Oct 31, 2022
Q2 2022 -5.25 +42 +88.9% May 1, 2022 Jul 31, 2022
Q1 2022 -6.02 +38.3 +86.4% Feb 1, 2022 Apr 30, 2022
Q4 2021 -7.62 +35.8 +82.5% Nov 1, 2021 Jan 31, 2022
Q3 2021 -13 +36.7 +73.8% Aug 1, 2021 Oct 31, 2021
Q2 2021 -47.3 +11.7 +19.8% May 1, 2021 Jul 31, 2021
Q1 2021 -44.3 +23.9 +35% Feb 1, 2021 Apr 30, 2021
Q4 2020 -43.4 +33 +43.2% Nov 1, 2020 Jan 31, 2021
Q3 2020 -49.6 +21.6 +30.3% Aug 1, 2020 Oct 31, 2020
Q2 2020 -58.9 +9.52 +13.9% May 1, 2020 Jul 31, 2020
Q1 2020 -68.2 -2.5 -3.81% Feb 1, 2020 Apr 30, 2020
Q4 2019 -76.4 -9.9 -14.9% Nov 1, 2019 Jan 31, 2020
Q3 2019 -71.2 +13.7 +16.1% Aug 1, 2019 Oct 31, 2019
Q2 2019 -68.5 +21.9 +24.2% May 1, 2019 Jul 31, 2019
Q1 2019 -65.7 +23.6 +26.5% Feb 1, 2019 Apr 30, 2019
Q4 2018 -66.5 +15 +18.4% Nov 1, 2018 Jan 31, 2019
Q3 2018 -84.9 -14.4 -20.5% Aug 1, 2018 Oct 31, 2018
Q2 2018 -90.4 -27.7 -44.1% May 1, 2018 Jul 31, 2018
Q1 2018 -89.3 -31.1 -53.5% Feb 1, 2018 Apr 30, 2018
Q4 2017 -81.5 -20.7 -34.1% Nov 1, 2017 Jan 31, 2018
Q3 2017 -70.5 -3.56 -5.32% Aug 1, 2017 Oct 31, 2017
Q2 2017 -62.7 +10.1 +13.9% May 1, 2017 Jul 31, 2017
Q1 2017 -58.2 +17.3 +22.9% Feb 1, 2017 Apr 30, 2017
Q4 2016 -60.8 +43.9 +41.9% Nov 1, 2016 Jan 31, 2017
Q3 2016 -66.9 +38.1 +36.3% Aug 1, 2016 Oct 31, 2016
Q2 2016 -72.8 +52.1 +41.7% May 1, 2016 Jul 31, 2016
Q1 2016 -75.5 +53.5 +41.5% Feb 1, 2016 Apr 30, 2016
Q4 2015 -105 +186 +64% Nov 1, 2015 Jan 31, 2016
Q3 2015 -105 +182 +63.4% Aug 1, 2015 Oct 31, 2015
Q2 2015 -125 +223 +64.1% May 1, 2015 Jul 31, 2015
Q1 2015 -129 +346 +72.8% Feb 1, 2015 Apr 30, 2015
Q4 2014 -291 -21.7 -8.07% Nov 1, 2014 Jan 31, 2015
Q3 2014 -287 +44.7 +13.5% Aug 1, 2014 Oct 31, 2014
Q2 2014 -348 -140 -67% May 1, 2014 Jul 31, 2014
Q1 2014 -475 -410 -634% Feb 1, 2014 Apr 30, 2014
Q4 2013 -269 -191 -244% Nov 1, 2013 Jan 31, 2014
Q3 2013 -331 -253 -322% Aug 1, 2013 Oct 31, 2013
Q2 2013 -209 -121 -139% May 1, 2013 Jul 31, 2013
Q1 2013 -64.7 +40 +38.2% Feb 1, 2013 Apr 30, 2013
Q4 2012 -78.1 +77.3 +49.7% Nov 1, 2012 Jan 31, 2013
Q3 2012 -78.6 Aug 1, 2012 Oct 31, 2012
Q2 2012 -87.2 May 1, 2012 Jul 31, 2012
Q1 2012 -105 Feb 1, 2012 Apr 30, 2012
Q4 2011 -155 Nov 1, 2011 Jan 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.